Last reviewed · How we verify
PEG-rhGH with present preparation
At a glance
| Generic name | PEG-rhGH with present preparation |
|---|---|
| Sponsor | Changchun GeneScience Pharmaceutical Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Bioequivalence Study of Two Different PEG-rhGH Preparations (PHASE1)
- A Clinical Trail to Compare Pharmacokinetics of Two PEG-rhGH Injections With Different Preparations (PHASE1)
- A Clinical Trial to Compare Pharmacokinetics of Two Different PEG-rhGH Preparations (PHASE1)
- A Bioavailability Study of Two Different PEG-rhGH Preparations. (PHASE1)
- A Bioequivalence Study of Two Different Processes of PEG-rhGH Preparations (PHASE1)
- A Bioequivalence Study of Two Different PEG-rhGH Preparations. (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |